<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v3-xMedicine"/>
  <language value="en"/>
  <url value="http://terminology.hl7.org/ValueSet/v3-xMedicine"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.1.11.19668"/>
  </identifier>
  <version value="2.0.0"/>
  <name value="XMedicine"/>
  <title value="x_Medicine"/>
  <status value="active"/>
  <experimental value="false"/>
  <date value="2014-03-26"/>
  <publisher value="Health Level Seven International"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="http://hl7.org"/>
    </telecom>
    <telecom>
      <system value="email"/>
      <value value="hq@HL7.org"/>
    </telecom>
  </contact>
  <description value="A type of Administered Substance that is manufactured from raw organic or inorganic ingredients and used in the course of a patient&#39;s therapy."/>
  <copyright value="This material derives from the HL7 Terminology THO. THO is copyright Â©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license"/>
  <compose>
    <include>
      <system value="http://terminology.hl7.org/CodeSystem/v3-EntityCode"/>
      <concept>
        <code value="BLDPRD"/>
      </concept>
    </include>
    <include>
      <valueSet value="http://terminology.hl7.org/ValueSet/v3-VaccineEntityType"/>
    </include>
  </compose>
</ValueSet>